KYOWA KIRIN CO. LTD. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,748 JPY | +2.29% |
|
+1.59% | +15.93% |
| 05/06 | Kyowa Kirin Repurchases 3.3 Million Shares in May | MT |
| 07/05 | Kyowa Kirin's Profit Up 15% in Q1 | MT |
| Sales 2024 * | 47TCr 300.75Cr 25TCr | Sales 2025 * | 48TCr 308.04Cr 26TCr | Capitalization | 1,45500Cr 924.27Cr 77TCr |
|---|---|---|---|---|---|
| Net income 2024 * | 6.66TCr 42Cr 3.54TCr | Net income 2025 * | 7.25TCr 46Cr 3.85TCr | EV / Sales 2024 * | 2.38 x |
| Net cash position 2024 * | 33TCr 208.03Cr 17TCr | Net cash position 2025 * | 36TCr 228.65Cr 19TCr | EV / Sales 2025 * | 2.26 x |
| P/E ratio 2024 * |
21.9
x | P/E ratio 2025 * |
20.1
x | Employees | 5,974 |
| Yield 2024 * |
2.13% | Yield 2025 * |
2.23% | Free-Float | 45.41% |
More Fundamentals
* Assessed data
More news
More recommendations
More press releases
More news
| 1 day | +2.29% | ||
| 1 week | +1.59% | ||
| Current month | +3.46% | ||
| 1 month | +4.11% | ||
| 3 months | -2.92% | ||
| 6 months | +13.91% | ||
| Current year | +15.93% |
1 week
2 651.00
2 756.50
1 month
2 536.002 756.50
Current year
2 266.503 009.00
1 year
2 266.503 009.00
3 years
2 266.504 240.00
5 years
1 674.004 240.00
10 years
1 094.004 240.00
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | 01/86/01 | |
Masashi Miyamoto
PSD | President | 64 | 01/85/01 |
| Chief Tech/Sci/R&D Officer | 62 | 01/10/01 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Takashi Oyamada
BRD | Director/Board Member | 68 | 01/21/01 |
Yoshihisa Suzuki
BRD | Director/Board Member | 69 | 01/22/01 |
| Director/Board Member | 66 | 01/08/01 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.22% | 14 M€ | +9.43% | ||
| 0.44% | 10 M€ | +16.05% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 14/24/14 | 2,748 | +2.29% | 2,426,300 |
| 13/24/13 | 2,686 | -0.26% | 702,800 |
| 12/24/12 | 2,693 | -1.23% | 1,014,200 |
| 11/24/11 | 2,726 | -0.04% | 697,400 |
| 10/24/10 | 2,728 | +0.85% | 817,300 |
Delayed Quote Japan Exchange, June 14, 2024 at 11:30 am IST
More quotes
Kyowa Kirin Co., Ltd. specializes in the development, manufacturing and marketing of pharmaceutical and biochemical products. Net sales break down by source of revenue as follows:
- sales of pharmaceutical products (92.6%): prescription products for anemia, cancers, immune and nephrology diseases treatment;
- sales of licenses (7.4%).
At the end of 2021, the group had 3 production sites located in Japan (2) and China.
Net sales break down geographically as follows: Japan (60.9%), Asia (9%), Americas (16.3%) and Europe (13.8%).
Sector
Pharmaceuticals
Calendar
27/06/2024
- Détachement de for dividende intermédiaire
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
2,748
JPY
Average target price
3,054
JPY
Spread / Average Target
+11.16%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.93% | 924.76Cr | |
| +19.36% | 8TCr | |
| +42.06% | 444.73Cr | |
| -22.01% | 443.09Cr | |
| +8.28% | 402.94Cr | |
| +11.22% | 224.47Cr | |
| -26.61% | 218.19Cr | |
| +11.64% | 202.03Cr | |
| -42.69% | 179.07Cr | |
| -0.50% | 164.41Cr |
- Stock Market
- Equities
- 4151 Stock
